OMER : Analysis & Opinions

  1. Omeros Renal Drug Shows Promise in Phase II (OMER)

    October 17, 2016
    Omeros Corporation said its OMS721 drug produced positive results for treating kidney diseases in a Phase II trial.
  2. Omeros Corporation's Stock Surges

    August 20, 2015
    Omeros Corporation (OMER), a Seattle-based biopharmaceutical company, reported an additional positive data from a Phase 2 ...